The company purchased their own land and constructed the factory building as per the SCHEDULE "M" norms. Total plinth area of Factory is around 20,000 Sq. Feet and the floors are laid with
kota Stone, installed Air Handling Units (AHU) and Centralised Air Conditioner for each section separately. Separate Transformer erected electrical power, separate Generator also provided for 62.5 HP for undisturbed power supply.
We manufacture capsule, coated/uncoated tablets, liquid orals, external solution and ointment preparations and separate antibiotic manufacturing facilities. We make both allopathic and ayurvedic preparations at Schedule - M and T standards.
Our factory capacity is in excess of 34000 Sq ft with centralized air conditioners in WHO-GMP complying standards, ISO 9001-2000 certified with standards complying UK-MHRA. As an affiliated member of PMA, IDMA and TASUMA Biomiicron is having sufficient spare capacity for Third Party arrangements to manufacture formulations.
Biomiicron Pharmaceuticals has in place all the key capabilities critical to this business - manufacturing, process development (integrating with R&D), IPR protection, BD and supply chain management.
Significantly, Biomiicron Pharmaceuticals is also well placed to offer manufacturing services across the entire life cycle of a product, including the development stage. Biomiicron's capabilities today include not just lower cost dosage manufacturing, but the ability to manage costs through process innovation and the skills to aid in formulations R&D development and New Drug Delivery Systems.